IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 41.099
EU - Europa 32.310
AS - Asia 14.000
SA - Sud America 2.607
AF - Africa 215
Continente sconosciuto - Info sul continente non disponibili 151
OC - Oceania 39
Totale 90.421
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.808
RU - Federazione Russa 9.235
GB - Regno Unito 7.635
SG - Singapore 6.573
IT - Italia 4.648
CN - Cina 3.091
DE - Germania 2.675
UA - Ucraina 2.546
BR - Brasile 2.273
CA - Canada 2.006
HK - Hong Kong 1.744
DK - Danimarca 1.575
VN - Vietnam 1.235
SE - Svezia 867
IE - Irlanda 719
FR - Francia 624
FI - Finlandia 617
PL - Polonia 356
IN - India 246
NL - Olanda 241
MX - Messico 200
TR - Turchia 189
AT - Austria 159
EU - Europa 149
BD - Bangladesh 136
PK - Pakistan 114
AR - Argentina 100
ES - Italia 100
ID - Indonesia 91
IQ - Iraq 87
JP - Giappone 77
ZA - Sudafrica 70
LT - Lituania 59
KR - Corea 53
UZ - Uzbekistan 53
EC - Ecuador 52
IR - Iran 52
CO - Colombia 46
AE - Emirati Arabi Uniti 45
BE - Belgio 44
VE - Venezuela 44
SK - Slovacchia (Repubblica Slovacca) 43
MA - Marocco 36
SA - Arabia Saudita 35
CH - Svizzera 31
PE - Perù 28
RO - Romania 28
CZ - Repubblica Ceca 26
AU - Australia 24
KE - Kenya 22
CL - Cile 19
JO - Giordania 19
UY - Uruguay 19
EG - Egitto 17
IL - Israele 17
PT - Portogallo 17
AM - Armenia 16
JM - Giamaica 16
TN - Tunisia 16
AZ - Azerbaigian 15
PH - Filippine 15
BO - Bolivia 14
DZ - Algeria 14
NZ - Nuova Zelanda 13
TT - Trinidad e Tobago 13
TW - Taiwan 12
NP - Nepal 11
CR - Costa Rica 10
KG - Kirghizistan 9
MY - Malesia 9
OM - Oman 9
PY - Paraguay 9
BB - Barbados 8
HN - Honduras 8
MC - Monaco 8
TH - Thailandia 8
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 7
GE - Georgia 7
HU - Ungheria 7
NI - Nicaragua 7
GT - Guatemala 6
KZ - Kazakistan 6
PA - Panama 6
PS - Palestinian Territory 6
RS - Serbia 6
AL - Albania 5
AO - Angola 5
BH - Bahrain 5
ET - Etiopia 5
GR - Grecia 5
MG - Madagascar 5
MT - Malta 5
NO - Norvegia 5
BY - Bielorussia 4
EE - Estonia 4
HR - Croazia 4
LB - Libano 4
LV - Lettonia 4
NG - Nigeria 4
Totale 90.377
Salva come PNG Salva come JPEG
Città #
Southend 5.518
Singapore 3.874
Woodbridge 2.866
Chandler 2.554
Ann Arbor 2.547
Beijing 2.332
Houston 2.207
Fairfield 1.913
San Mateo 1.857
Chicago 1.642
Falls Church 1.553
Hong Kong 1.519
Dearborn 1.327
Ashburn 1.289
Seattle 1.272
Jacksonville 1.195
Cambridge 1.143
Wilmington 1.143
Los Angeles 961
Moscow 957
Ottawa 943
Salt Lake City 718
Boardman 704
Dublin 703
Stevenage 685
Portsmouth 682
The Dalles 663
Dong Ket 641
Pisa 593
Lawrence 525
Beauharnois 444
Tampa 407
Montréal 406
Munich 397
Buffalo 385
Milan 344
Santa Clara 340
Warsaw 333
Brooklyn 321
Elk Grove Village 321
Rome 285
London 233
San Diego 213
São Paulo 202
Dallas 185
Florence 181
New York 181
Frankfurt am Main 169
Redwood City 160
Old Bridge 158
Nuremberg 153
Sterling 151
Lancaster 145
Helsinki 125
Central District 114
Miami 108
Istanbul 106
Turku 102
Dulles 95
Fremont 91
Lappeenranta 89
San Francisco 89
Norwalk 85
Boston 80
Rio de Janeiro 80
Washington 80
Bologna 79
Kansas City 79
Phoenix 74
Guangzhou 70
Lucca 66
Belo Horizonte 65
Mexico City 65
Toronto 65
Detroit 63
Genoa 59
Livorno 59
Montreal 58
Stockholm 58
Vienna 58
Atlanta 57
Shanghai 57
Tokyo 56
Amsterdam 53
Shenzhen 53
Chennai 51
Assago 50
Brasília 50
Tashkent 49
Turin 48
Naples 45
Bratislava 43
Düsseldorf 43
Johannesburg 43
Pittsburgh 43
Lauterbourg 41
Paris 41
Wayne 41
Curitiba 40
Hanoi 38
Totale 55.744
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.722
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.497
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.403
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 1.194
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 757
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 477
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 339
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 310
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 281
La neuropatia diabetica 273
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 263
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 260
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 254
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 244
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 230
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 226
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 222
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 220
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 220
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 217
Treating chemoreflex in heart failure: modulation or demolition? 216
Building medical knowledge from real world registries: The case of heart failure 216
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 215
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 214
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 214
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 213
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 212
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 212
Cartella clinica automatizzata per il reparto di cardiologia 211
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 210
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 208
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 206
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 206
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 206
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 205
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 205
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 205
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 204
An Open System for Managing Long Term ECG Recordings 203
Development of an Electronic Medical Record for Patient Care in Cardiology 202
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 201
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 200
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 200
Nuovi strumenti di management per la gestione integrata dei percorsi assistenziali dei pazienti cronici 199
Medical record System for Cardiology and Cardiac Surgery 198
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 198
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 198
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 197
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 197
Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation 194
B-type natriuretic peptide secretion following scuba diving 194
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 194
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 194
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. 193
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. 193
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 193
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 192
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 192
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 191
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 191
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 190
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 189
Effects of smoking in patients treated with cardiac resynchronization therapy 187
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 187
Development of an Electronic Medical Record System for the Department of Cardiology 186
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 186
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 186
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 185
Valutazione esterna di qualità dei peptidi natriuretici BNP e NT-proBNP: risultati del programma Cardioormocheck 185
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 185
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 184
These abstracts have been selected for moderated presentations on SCREEN A. Please refer to the the PROGRAM and the infos on the screen for more details about schedule, moderators and presenters. 184
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 184
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 184
Prediction of the chemoreflex gain by common clinical variables in heart failure 184
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 184
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 183
Distribution of plasma cardiac troponin-I values in healthy subjects: pathophysiological considerations 183
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 183
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 182
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 182
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption 182
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 181
Attivazione adrenergica e deattivazione parasimpatica nello scompenso cardiaco. 181
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 181
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 181
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 181
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 180
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 180
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 180
ST segment/heart rate hysteresis improves the diagnostic accuracy of ECG stress test for coronary artery disease in patients with left ventricular hypertrophy 180
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 180
Cardiac production of C-type natriuretic peptide in heart failure. 179
Update sui biomarcatori nello scompenso cardiaco. 179
Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy 179
C-type natriuretic peptide and heart failure 178
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 178
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 178
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 178
Chronotropic response to vasodilator-stress in patients submitted to myocardial perfusion imaging: impact on the accuracy in detecting coronary stenosis 178
Totale 25.998
Salva come PNG Salva come JPEG
Categoria #
all - tutte 586.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 586.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110.832 0 1.246 530 894 633 1.601 1.075 605 923 664 1.040 1.621
2021/20228.856 788 1.557 404 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/202534.921 265 325 1.822 648 1.291 1.781 4.145 7.450 2.628 3.835 6.773 3.958
2025/20264.327 4.297 30 0 0 0 0 0 0 0 0 0 0
Totale 91.293